Maltecca Greta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maltecca Greta has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Mangano
Division of General, Minimally Invasive and Robotic Surgery, University of Illinois at Chicago, Chicago, IL, USA -
1 shared publication - Alice Bonetti
Senology Research Center, Department of Medicine and Innovation Technology (DiMIT), University of Insubria, 21100 Varese, Italy
1 shared publication - Andrea Ballabio
Department of Medicine and Innovation Technology (DiMIT), University of Insubria, 21100 Varese, Italy
1 shared publication - Corrado Chiappa
Department of General Surgery, University of Insubria, Varese, Italy
1 shared publication - Davide Inversini
General, Emergency and Transplant Surgery Department, ASST Settelaghi, University of Insubria, 21100 Varese, Italy
1 shared publication - Francesca Rovera
Senology Research Center, Department of Medicine and Innovation Technology (DiMIT), University of Insubria, 21100 Varese, Italy
1 shared publication
Latest Publications
- Open Access
Neoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis
The correlation between TNM staging and histology variations in a sample of patients who underwent neoadjuvant chemotherapy demonstrates a positive impact on both increasing conservative surgery and achieving pCR, resulting in better outcomes in terms of disease-free survival (DFS) and the risk of relapse. Benefits have also been highlighted in terms of cosmetic outcomes, postoperative complications, and psychological benefits. However, the overall outcomes must be evaluated according to the subtype and individual characteristics of the patients.
Open AccessNeoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis
The correlation between TNM staging and histology variations in a sample of patients who underwent neoadjuvant chemotherapy demonstrates a positive impact on both increasing conservative surgery and achieving pCR, resulting in better outcomes in terms of disease-free survival (DFS) and the risk of relapse. Benefits have also been highlighted in terms of cosmetic outcomes, postoperative complications, and psychological benefits. However, the overall outcomes must be evaluated according to the subtype and individual characteristics of the patients.